Jpmorgan Chase & CO Medical Devices

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ELMD Electromed, Inc.	$172M	$705,000 0.0% of portfolio	29,572	Q1 2025 Added 86,876.47%
DCTH Delcath Systems, Inc.	$139M	$650,000 0.0% of portfolio	51,127	Q1 2025 New
PACB Pacific Biosciences Of California, Inc.	$216M	$615,000 0.0% of portfolio	521,334	Q1 2025 Added 1.33%
ANIK Anika Therapeutics, Inc.	$163M	$558,000 0.0% of portfolio	37,145	Q1 2025 Reduced 54.97%
NPCE Neuro Pace Inc	$328M	$538,000 0.0% of portfolio	43,792	Q1 2025 Reduced 32.45%
MYO Myomo, Inc.	$20.8M	$527,000 0.0% of portfolio	109,568	Q1 2025 Added 21.54%
NVNO En V Veno Medical Corp	$34.2M	$510,000 0.0% of portfolio	194,213	Q1 2025 Reduced 28.08%
SNN Smith & Nephew PLC	$12.6B	$507,000 0.0% of portfolio	17,900	Q1 2025 Added 27.67%
ARAY Accuray Inc	$143M	$479,000 0.0% of portfolio	267,616	Q1 2025 Added 10.26%
SGHT Sight Sciences, Inc.	$176M	$370,000 0.0% of portfolio	154,529	Q1 2025 Added 45.3%
TCMD Tactile Systems Technology Inc	$199M	$304,000 0.0% of portfolio	23,012	Q1 2025 Reduced 45.16%
CLPT Clear Point Neuro, Inc.	$289M	$287,000 0.0% of portfolio	24,209	Q1 2025 Added 4,317.7%
MXCT Maxcyte, Inc.	$242M	$252,000 0.0% of portfolio	92,324	Q1 2025 Reduced 39.24%
BWAY Brainsway Ltd.	$168M	$240,000 0.0% of portfolio	25,374	Q1 2025 Added 6.09%
NNOX Nano X Imaging Ltd.	$267M	$203,000 0.0% of portfolio	40,735	Q1 2025 Added 20.11%
KIDS Orthopediatrics Corp	$457M	$201,000 0.0% of portfolio	8,163	Q1 2025 Reduced 80.94%
TELA Tela Bio, Inc.	$26.6M	$132,000 0.0% of portfolio	108,367	Q1 2025 Reduced 18.93%
CERS Cerus Corp	$225M	$124,000 0.0% of portfolio	89,547	Q1 2025 Reduced 50.77%
SMLR Semler Scientific, Inc.	$272M	$121,000 0.0% of portfolio	3,367	Q1 2025 Added 44.88%
QIPT Quipt Home Medical Corp.	$63.4M	$117,000 0.0% of portfolio	50,525	Q1 2025 Reduced 51.3%
RCEL Avita Medical, Inc.	$141M	$102,000 0.0% of portfolio	12,593	Q1 2025 Reduced 76.11%
MASS 908 Devices Inc.	$179M	$56,000 0.0% of portfolio	12,534	Q1 2025 Added 6.7%
FONR Fonar Corp	$95M	$42,000 0.0% of portfolio	3,000	Q1 2025 Reduced 0.07%
LNSR Lensar, Inc.	$149M	$9,000 0.0% of portfolio	683	Q1 2025 Added 173.2%
SENS Senseonics Holdings, Inc.	$242M	$9,000 0.0% of portfolio	14,612	Q3 2024 Reduced 90.85%
ICCM Ice Cure Medical Ltd.	$38.7M	$7,000 0.0% of portfolio	5,950	Q3 2023 New
BFLY Butterfly Network, Inc.	$415M	$2,000 0.0% of portfolio	1,005	Q1 2025 Reduced 11.14%
XAIR Beyond Air, Inc.	$5.38M	$1,000 0.0% of portfolio	6,824	Q1 2025 Reduced 8.03%
APYX Apyx Medical Corp	$53.9M	$0 0.0% of portfolio	60	Q1 2025 Reduced 7.69%
CODX Co Diagnostics, Inc.	$8.78M	$0 0.0% of portfolio	76	Q4 2021 Reduced 5.0%
CTSO Cytosorbents Corp	$36.6M	$0 0.0% of portfolio	485	Q1 2025 Reduced 1.82%
HYPR Hyperfine, Inc.	$33.3M	$0 0.0% of portfolio	118	Q1 2025 Reduced 7.81%
IRIX Iridex Corp	$16M	$0 0.0% of portfolio	27	Q1 2025 Reduced 10.0%
LUCD Lucid Diagnostics Inc.	$53.6M	$0 0.0% of portfolio	46	Q1 2025 Reduced 6.12%
MODD Modular Medical, Inc.	$9.39M	$0 0.0% of portfolio	61	Q1 2025 Reduced 10.29%
NMTC Neuroone Medical Technologies Corp	$9.89M	$0 0.0% of portfolio	61	Q1 2025 Reduced 7.58%
RPID Rapid Micro Biosystems, Inc.	$121M	$0 0.0% of portfolio	109	Q1 2025 Reduced 30.57%
XTNT Xtant Medical Holdings, Inc.	$71.4M	$0 0.0% of portfolio	102	Q1 2025 Reduced 8.11%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.